Wuhan Keqian Biology Co Ltd (688526) — Financial Flexibility Index
Wuhan Keqian Biology Co Ltd (688526) has a Financial Flexibility Index of 0.32x as of September 2025. Free cash flow of CN¥185.71 Million (operating CF CN¥174.36 Million minus capex CN¥11.35 Million) represents 0% of total liabilities (CN¥580.21 Million). Check financial resilience of Wuhan Keqian Biology Co Ltd to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Wuhan Keqian Biology Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Wuhan Keqian Biology Co Ltd across 9 annual periods. See Wuhan Keqian Biology Co Ltd (688526) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Wuhan Keqian Biology Co Ltd. For the full company profile including market capitalisation, see 688526 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.90x | CN¥499.63 Million | CN¥392.68 Million | CN¥552.80 Million | ▲ +17.3% |
| 2023 | 0.77x | CN¥642.54 Million | CN¥538.03 Million | CN¥833.59 Million | ▲ +30.5% |
| 2022 | 0.59x | CN¥526.56 Million | CN¥423.71 Million | CN¥891.63 Million | ▼ -62.7% |
| 2021 | 1.59x | CN¥905.72 Million | CN¥531.27 Million | CN¥571.41 Million | ▲ +24.6% |
| 2020 | 1.27x | CN¥511.73 Million | CN¥400.14 Million | CN¥402.40 Million | ▲ +9.7% |
| 2019 | 1.16x | CN¥292.62 Million | CN¥154.89 Million | CN¥252.48 Million | ▲ +6.9% |
| 2018 | 1.08x | CN¥383.26 Million | CN¥351.83 Million | CN¥353.51 Million | ▼ -39.9% |
| 2017 | 1.80x | CN¥466.73 Million | CN¥337.61 Million | CN¥258.86 Million | ▲ +29.2% |
| 2016 | 1.40x | CN¥249.82 Million | CN¥220.69 Million | CN¥179.01 Million | — |